Financings
Blusky Carbon increases loan to $5.68-million (U.S.)
Blusky Carbon Faces Trading Halt Amid Debt Restructuring and Regulatory Scrutiny
Executive Summary
- Loan Amendment (April 9, 2026): Blusky Carbon amended an arm's-length loan agreement, increasing principal to $5.68 million USD with a six-month maturity from the advance date.
- Debenture Amendments: Secured debenture maturity extended to September 30, 2026, with $400,000 received and $150,000 extension fee paid. Convertible debenture principal increased from $750,000 to $900,000 in exchange for a waiver of default rights.
- Trading Suspension (January 7, 2026): CIRO and CSE issued trading halts under NI 23-101. A cease-trade order was issued by the British Columbia Securities Commission.
- Asset Purchase & Financing (December 2025/2026): Company entered an $8.31 million asset purchase deal for its Arkansas biochar facility (AR1). Terms include a $400,000 closing payment received and seller-financed balance of $7.51 million at 1.99% interest over 12 years.
- Management Changes: CFO Andrew Duval resigned; Will Hessert appointed interim CFO. Director Alex McAulay resigned.
- Debt Settlement (December 2025): Issued ~293,785 shares to settle $17,333 of debt at a deemed price of $0.059 per share.
Material Impact
- Regulatory Halt is Critical: The cease-trade order issued in January 2026 represents a severe regulatory breach or compliance failure that typically precedes delisting or forced restructuring. This halts liquidity and prevents the company from raising equity capital through the market.
- Debt Burden Increases: Despite the trading halt, the company increased its loan principal to $5.68 million USD in April 2026. This creates a significant short-term liability ($400k payment received vs. new debt) with a maturity of only six months from the advance date (October 2026).
- Cash Flow Strain: The company paid a $150,000 extension fee on debentures while simultaneously increasing principal. This indicates cash is being consumed to service existing debt rather than fund operations.
- Data Discrepancy Risk: Price data shows trading activity through April 8, 2026 ($0.05), contradicting the January 7, 2026 suspension notice. If trading occurred during a cease-trade order, this suggests further regulatory non-compliance or that the price data is stale/misreported. This uncertainty adds significant risk to valuation.
- Management Turnover: CFO resignation combined with interim appointment signals potential instability in financial oversight during a critical liquidity crunch.
BSKY · Price
Company Overview
- Company: Blusky Carbon Inc. focuses on carbon capture and biochar production.
- Flagship Project: AR1 Arkansas biochar facility. The company sold ownership of the assets to WARB1 LLC but retains exclusive operations, maintenance, and asset management rights.
- Business Model: Turnkey acquisition with seller financing (Blusky finances the buyer) and ongoing O&M fees. This model aims to unlock capital for future projects by offloading asset ownership while retaining revenue streams.
- Development Status: AR1 facility is in operation/commissioning phase, but financial restructuring suggests liquidity pressure on the parent company despite project-level cash flow.